Latest Breaking News On - Junshi biosciences contact information ir team - Page 1 : comparemela.com

- Toripalimab plus chemotherapy demonstrates improvement in co-primary endpoints of PFS and OS in patients with advanced ESCC -

United statesSan franciscoPatricia keeganDenny lanfearCoherus biosciencesSheng yaoEli lillyRuihua xuMcdavid stilwellJunshi biosciencesJunshi biosciences zhi liInstitute of microbiology chinese academyCoherus biosciences incDrug administrationJunshi biosciences contact information ir teamSun yat sen university cancer center